![Zachary A. Zimmerman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zachary A. Zimmerman
Fondateur chez Forge Therapeutics, Inc.
Postes actifs de Zachary A. Zimmerman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Forge Therapeutics, Inc.
![]() Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 16/05/2017 | - |
Directeur Général | - | - | |
Fondateur | - | - | |
Blacksmith Medicines, Inc.
![]() Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | Directeur Général | - | - |
Fondateur | - | - |
Historique de carrière de Zachary A. Zimmerman
Anciens postes connus de Zachary A. Zimmerman
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
Arcturus Therapeutics, Inc.
![]() Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Zachary A. Zimmerman
University of California, Santa Cruz | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Arcturus Therapeutics, Inc.
![]() Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Forge Therapeutics, Inc.
![]() Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Health Technology |
Blacksmith Medicines, Inc.
![]() Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Zachary A. Zimmerman
- Expérience